Verition Fund Management »

Rapport Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $236k 7.5k 31.29

More positions owned by Verition Fund Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Select Sector Spdr Tr State Street Con (XLP)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Warner Bros Discovery Com Ser A (WBD)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Norfolk Southern (NSC)
Advanced Micro Devices (AMD)
Electronic Arts (EA)
Select Sector Spdr Tr State Street Fin (XLF)
Spdr Gold Tr Gold Shs (GLD)
Sealed Air
Old National Ban (ONB)

View all positions for Verition Fund Management

Top funds holding Rapport Therapeutics

FMR
TRV GP V
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Johnson & Johnson
Polar Capital Holdings
Baker Bros. Advisors
Vestal Point Capital
Vanguard Capital Management
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics